FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Surrogate who refused abortion asks SCOTUS to intervene as baby could be moved out of Texas

Georgia mayor, 23, ousted 10 months after making history as state’s youngest mayor

Republicans Attack GOP Candidate for Pointing Out How Many Foreign Students Attended Texas-Ohio State Game

Breaking: SCOTUS Blocks Trump’s Mail-in Ballot Restrictions Months Before Midterms

‘Trojan horses’ in America: Congress probes influence networks tied to China, Iran and Cuba

House Dems face Trump tariff dilemma as major Russia sanctions bill heads to floor

Supreme Court rejects Trump bid to revive strict mail-ballot rules before midterms

Trump Gives Huge Update on Russia-Ukraine War That Could Ease Pain at the Gas Pumps

GOP Gov. Candidate Forced to Swim for His Life After Plane Crash – Reporter Says Water Was ‘Only 30 Feet’ Deep

Saudi Arabia appeals to US as pipeline closure and Houthis spike oil prices

Michigan Senate candidate Abdul El-Sayed says leaders must address ‘unpaid debts’ to Black communities

Elon Musk PAC Steps Up with Big Bucks to Fund Key Swing-State Races

Ex-Dem insider exposes what Harris told top donors days before Biden dropped out: ‘Insulting’

Breaking Video: Police Gathered at Mitch McConnell’s Residence – Comes After 95 Days Away from Senate, Questions About Health Concerns

Mitch McConnell casts first Senate vote since June fall

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”